Contact Us
Hydronephrosis Global Market Report 2025
Global Hydronephrosis Market Report 2025
Item added to cart!

Published : December 2025

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Hydronephrosis Global Market Report 2025

By Type (Unilateral Hydronephrosis, Bilateral Hydronephrosis), By Indication (Intrinsic, Extrinsic), By Diagnosis (Laboratory Test, Imaging), By Treatment (Shock Wave Lithotripsy, Laparoscopy, Bladder Catheterization, Steroid Therapy, Other Treatments) – Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Hydronephrosis Market?

Hydronephrosis is a medical condition characterized by the swelling of one or both kidneys due to a buildup of urine. This occurs when the flow of urine is obstructed, causing the kidneys to become enlarged. It can result from blockages such as kidney stones, tumors, or anatomic abnormalities, and may lead to kidney damage if left untreated.

The main types of hydronephrosis are unilateral hydronephrosis and bilateral hydronephrosis. Unilateral hydronephrosis is a condition where one kidney becomes swollen due to a buildup of urine caused by an obstruction or other issues in the urinary tract on that side. It is classified by its indication as either intrinsic or extrinsic. Diagnostics is primarily achieved through laboratory tests and imaging. Treatment options include shock wave lithotripsy, laparoscopy, bladder catheterization, steroid therapy, and others.

Hydronephrosis Market Size and growth rate 2025 to 2029: Graph

What Is The Hydronephrosis Market Size 2025 And Growth Rate?

The hydronephrosis market size has grown rapidly in recent years. It will grow from $3.06 billion in 2024 to $3.38 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to the increasing prevalence of kidney stones, rising incidence of urinary tract infections, growth in the geriatric population, increasing awareness and early diagnosis, and rising healthcare expenditure.

What Is The Hydronephrosis Market Growth Forecast?

The hydronephrosis market size is expected to see rapid growth in the next few years. It will grow to $4.99 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to the increasing prevalence of chronic kidney diseases, rising adoption of minimally invasive surgeries, growing awareness about early detection, expansion of healthcare infrastructure, and development of new treatment options. Major trends in the forecast period include growth in personalized medicine, increasing use of artificial intelligence in diagnostics, advancements in non-invasive treatment methods, rise in patient-centric healthcare approaches, and integration of telemedicine in nephrology.

Customer representative image Book your 30 minutes free consultation with our research experts

How Is The Hydronephrosis Market Segmented?

The hydronephrosis market covered in this report is segmented –

1) By Type: Unilateral Hydronephrosis, Bilateral Hydronephrosis

2) By Indication: Intrinsic, Extrinsic

3) By Diagnosis: Laboratory Test, Imaging

4) By Treatment: Shock Wave Lithotripsy, Laparoscopy, Bladder Catheterization, Steroid Therapy, Other Treatments

Subsegments:

1) By Unilateral Hydronephrosis: Congenital Unilateral Hydronephrosis, Acquired Unilateral Hydronephrosis, Obstructive Unilateral Hydronephrosis, Non-Obstructive Unilateral Hydronephrosis

2) By Bilateral Hydronephrosis: Congenital Bilateral Hydronephrosis, Acquired Bilateral Hydronephrosis, Obstructive Bilateral Hydronephrosis, Non-Obstructive Bilateral Hydronephrosis

What Is Driving The Hydronephrosis Market? The Growing Burden Of Kidney Diseases Fuels Hydronephrosis Market Expansion

The rising prevalence of kidney diseases is expected to propel the growth of the hydronephrosis market going forward. Kidney disease, also known as renal disease or nephropathy, refers to a range of conditions that result in damage to the kidneys, impairing their ability to filter blood effectively. The increasing cases of kidney diseases are due to several factors, such as the rising incidence of diabetes and hypertension, obesity, the aging population, and genetic and ethnic factors. Hydronephrosis is treated by addressing the underlying cause of the urinary obstruction, which may involve medications, surgery, or other interventions to restore normal urine flow. For instance, in June 2023, according to the report published by Kidney Research UK, a UK-based non-profit organization, currently, approximately 7.2 million people in the UK are living with chronic kidney disease, representing over 10% of the population. Of these, 3.25 million are in the advanced stages of the disease, while an additional 3.9 million are in the early stages. By 2033, the number of individuals affected by chronic kidney disease is projected to rise to 7.61 million. Therefore, the rising prevalence of kidney diseases is driving the growth of the hydronephrosis market.

Who Are The Major Players In The Global Hydronephrosis Market?

Major companies operating in the hydronephrosis market are AbbVie Inc., Boston Scientific Corporation, Novartis AG, 3M Company, F. Hoffmann-La Roche Ltd, Medtronic PLC, Amgen Inc., Stryker Corporation, Thermo Fisher Scientific Inc., B. Braun Group, Terumo Interventional Systems, Sigma-Aldrich Co, Coloplast A/S, Cook Medical, KARL STORZ SE & Co. KG, Spire Healthcare Group plc, Promega Corporation, NantHealth Inc., UroGen Pharma Ltd., Natus Medical Incorporated, Renal Associates P.A., Urologix Inc., Savant Medical Group

What Are The Key Trends Of The Global Hydronephrosis Market? Advancements In Hydronephrosis Treatment Enhanced Patient Care

Major companies operating in the hydronephrosis market are developing innovative products such as drainage catheters to enhance patient care by providing efficient and minimally invasive solutions for draining urine from the kidneys. Drainage catheters are medical devices used to remove fluids, such as urine or blood, from the body to relieve pressure or prevent fluid accumulation. For instance, in October 2024, Argon Medical Devices Inc. is a US-based manufacturer of specialty medical products, launched the SKATER mini-loop drainage catheter. This catheter is a medical device designed for the minimally invasive drainage of unwanted fluid collections in the body. It is inserted through the skin using imaging guidance and features a loop that is 40% smaller, ensuring secure placement and effective drainage from smaller cavities. Known for its durability, kink resistance, and compatibility with alcohol, this catheter enhances usability in interventional procedures. By expanding Argon's drainage portfolio, the SKATER Mini-Loop aims to improve patient outcomes and streamline the drainage process for healthcare professionals.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Hydronephrosis Market? Laborie Medical Technologies Acquires Urotronic Inc. To Expand The Urology Portfolio And Advance Innovative Treatments

In October 2023, Laborie Medical Technologies Corp., a US-based diagnostic company, acquired Urotronic Inc. for an undisclosed amount. The acquisition enhances Laborie's urology portfolio by offering proven, innovative solutions to physicians and patients worldwide. It enables Laborie to advance cutting-edge technologies to address unmet medical needs and deliver solutions that preserve and restore human dignity. Urotronic Inc. is a US-based medical device company that specializes in developing innovative treatments for urological conditions.

What Is The Regional Outlook For The Global Hydronephrosis Market?

North America was the largest region in the hydronephrosis market in 2024. The regions covered in the hydronephrosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hydronephrosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Hydronephrosis Market?

The hydronephrosis market includes revenues earned by entities by providing services such as urine flow monitoring, follow-up care, and minimally invasive procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Hydronephrosis Industry?

The hydronephrosis market research report is one of a series of new reports from The Business Research Company that provides hydronephrosis market statistics, including hydronephrosis industry global market size, regional shares, competitors with a hydronephrosis market share, detailed hydronephrosis market segments, market trends and opportunities, and any further data you may need to thrive in the hydronephrosis industry. This hydronephrosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Author : Abdul Wasay

Hydronephrosis Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 3.38 billion
Revenue Forecast In 2034 $4.99 billion
Growth Rate CAGR of 10.2% from 2024 to 2033
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The hydronephrosis market covered in this report is segmented –
1) By Type: Unilateral Hydronephrosis, Bilateral Hydronephrosis
2) By Indication: Intrinsic, Extrinsic
3) By Diagnosis: Laboratory Test, Imaging
4) By Treatment: Shock Wave Lithotripsy, Laparoscopy, Bladder Catheterization, Steroid Therapy, Other Treatments Subsegments:
1) By Unilateral Hydronephrosis: Congenital Unilateral Hydronephrosis, Acquired Unilateral Hydronephrosis, Obstructive Unilateral Hydronephrosis, Non-Obstructive Unilateral Hydronephrosis
2) By Bilateral Hydronephrosis: Congenital Bilateral Hydronephrosis, Acquired Bilateral Hydronephrosis, Obstructive Bilateral Hydronephrosis, Non-Obstructive Bilateral Hydronephrosis
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled AbbVie Inc., Boston Scientific Corporation, Novartis AG, 3M Company, F. Hoffmann-La Roche Ltd, Medtronic PLC, Amgen Inc., Stryker Corporation, Thermo Fisher Scientific Inc., B. Braun Group, Terumo Interventional Systems, Sigma-Aldrich Co, Coloplast A/S, Cook Medical, KARL STORZ SE & Co. KG, Spire Healthcare Group plc, Promega Corporation, NantHealth Inc., UroGen Pharma Ltd., Natus Medical Incorporated, Renal Associates P.A., Urologix Inc., Savant Medical Group
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Hydronephrosis Market Characteristics

3. Hydronephrosis Market Trends And Strategies

4. Hydronephrosis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Hydronephrosis Growth Analysis And Strategic Analysis Framework

5.1. Global Hydronephrosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Hydronephrosis Market Growth Rate Analysis

5.4. Global Hydronephrosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Hydronephrosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Hydronephrosis Total Addressable Market (TAM)

6. Hydronephrosis Market Segmentation

6.1. Global Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Unilateral Hydronephrosis

Bilateral Hydronephrosis

6.2. Global Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Intrinsic

Extrinsic

6.3. Global Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Laboratory Test

Imaging

6.4. Global Hydronephrosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Shock Wave Lithotripsy

Laparoscopy

Bladder Catheterization

Steroid Therapy

Other Treatments

6.5. Global Hydronephrosis Market, Sub-Segmentation Of Unilateral Hydronephrosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Congenital Unilateral Hydronephrosis

Acquired Unilateral Hydronephrosis

Obstructive Unilateral Hydronephrosis

Non-Obstructive Unilateral Hydronephrosis

6.6. Global Hydronephrosis Market, Sub-Segmentation Of Bilateral Hydronephrosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Congenital Bilateral Hydronephrosis

Acquired Bilateral Hydronephrosis

Obstructive Bilateral Hydronephrosis

Non-Obstructive Bilateral Hydronephrosis

7. Hydronephrosis Market Regional And Country Analysis

7.1. Global Hydronephrosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Hydronephrosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hydronephrosis Market

8.1. Asia-Pacific Hydronephrosis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hydronephrosis Market

9.1. China Hydronephrosis Market Overview

9.2. China Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hydronephrosis Market

10.1. India Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hydronephrosis Market

11.1. Japan Hydronephrosis Market Overview

11.2. Japan Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hydronephrosis Market

12.1. Australia Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hydronephrosis Market

13.1. Indonesia Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hydronephrosis Market

14.1. South Korea Hydronephrosis Market Overview

14.2. South Korea Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hydronephrosis Market

15.1. Western Europe Hydronephrosis Market Overview

15.2. Western Europe Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hydronephrosis Market

16.1. UK Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hydronephrosis Market

17.1. Germany Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hydronephrosis Market

18.1. France Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hydronephrosis Market

19.1. Italy Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hydronephrosis Market

20.1. Spain Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hydronephrosis Market

21.1. Eastern Europe Hydronephrosis Market Overview

21.2. Eastern Europe Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hydronephrosis Market

22.1. Russia Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hydronephrosis Market

23.1. North America Hydronephrosis Market Overview

23.2. North America Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hydronephrosis Market

24.1. USA Hydronephrosis Market Overview

24.2. USA Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hydronephrosis Market

25.1. Canada Hydronephrosis Market Overview

25.2. Canada Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hydronephrosis Market

26.1. South America Hydronephrosis Market Overview

26.2. South America Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hydronephrosis Market

27.1. Brazil Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hydronephrosis Market

28.1. Middle East Hydronephrosis Market Overview

28.2. Middle East Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hydronephrosis Market

29.1. Africa Hydronephrosis Market Overview

29.2. Africa Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hydronephrosis Market Competitive Landscape And Company Profiles

30.1. Hydronephrosis Market Competitive Landscape

30.2. Hydronephrosis Market Company Profiles

30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. 3M Company Overview, Products and Services, Strategy and Financial Analysis

30.2.5. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

31. Hydronephrosis Market Other Major And Innovative Companies

31.1. Medtronic PLC

31.2. Amgen Inc.

31.3. Stryker Corporation

31.4. Thermo Fisher Scientific Inc.

31.5. B. Braun Group

31.6. Terumo Interventional Systems

31.7. Sigma-Aldrich Co

31.8. Coloplast A/S

31.9. Cook Medical

31.10. KARL STORZ SE & Co. KG

31.11. Spire Healthcare Group plc

31.12. Promega Corporation

31.13. NantHealth Inc.

31.14. UroGen Pharma Ltd.

31.15. Natus Medical Incorporated

32. Global Hydronephrosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hydronephrosis Market

34. Recent Developments In The Hydronephrosis Market

35. Hydronephrosis Market High Potential Countries, Segments and Strategies

35.1 Hydronephrosis Market In 2029 - Countries Offering Most New Opportunities

35.2 Hydronephrosis Market In 2029 - Segments Offering Most New Opportunities

35.3 Hydronephrosis Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Hydronephrosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Hydronephrosis Market, Sub-Segmentation Of Unilateral Hydronephrosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Hydronephrosis Market, Sub-Segmentation Of Bilateral Hydronephrosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Hydronephrosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Hydronephrosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: AbbVie Inc. Financial Performance
  • Table 78: Boston Scientific Corporation Financial Performance
  • Table 79: Novartis AG Financial Performance
  • Table 80: 3M Company Financial Performance
  • Table 81: F. Hoffmann-La Roche Ltd Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Hydronephrosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Hydronephrosis Market, Sub-Segmentation Of Unilateral Hydronephrosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Hydronephrosis Market, Sub-Segmentation Of Bilateral Hydronephrosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Hydronephrosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Hydronephrosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: AbbVie Inc. Financial Performance
  • Figure 78: Boston Scientific Corporation Financial Performance
  • Figure 79: Novartis AG Financial Performance
  • Figure 80: 3M Company Financial Performance
  • Figure 81: F. Hoffmann-La Roche Ltd Financial Performance

Frequently Asked Questions

Hydronephrosis is a medical condition characterized by the swelling of one or both kidneys due to a buildup of urine. This occurs when the flow of urine is obstructed, causing the kidneys to become enlarged. It can result from blockages such as kidney stones, tumors, or anatomic abnormalities, and may lead to kidney damage if left untreated. For further insights on the Hydronephrosis market, request a sample here

The Hydronephrosis market major growth driver - The Growing Burden Of Kidney Diseases Fuels Hydronephrosis Market Expansion. For further insights on the Hydronephrosis market, request a sample here

The Hydronephrosis market size has grown strongly in recent years. The hydronephrosis market size has grown rapidly in recent years. It will grow from $3.06 billion in 2024 to $3.38 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to the increasing prevalence of kidney stones, rising incidence of urinary tract infections, growth in the geriatric population, increasing awareness and early diagnosis, and rising healthcare expenditure. The hydronephrosis market size is expected to see rapid growth in the next few years. It will grow to $4.99 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to the increasing prevalence of chronic kidney diseases, rising adoption of minimally invasive surgeries, growing awareness about early detection, expansion of healthcare infrastructure, and development of new treatment options. Major trends in the forecast period include growth in personalized medicine, increasing use of artificial intelligence in diagnostics, advancements in non-invasive treatment methods, rise in patient-centric healthcare approaches, and integration of telemedicine in nephrology. For further insights on the Hydronephrosis market, request a sample here

The hydronephrosis market covered in this report is segmented –
1) By Type: Unilateral Hydronephrosis, Bilateral Hydronephrosis
2) By Indication: Intrinsic, Extrinsic
3) By Diagnosis: Laboratory Test, Imaging
4) By Treatment: Shock Wave Lithotripsy, Laparoscopy, Bladder Catheterization, Steroid Therapy, Other Treatments Subsegments:
1) By Unilateral Hydronephrosis: Congenital Unilateral Hydronephrosis, Acquired Unilateral Hydronephrosis, Obstructive Unilateral Hydronephrosis, Non-Obstructive Unilateral Hydronephrosis
2) By Bilateral Hydronephrosis: Congenital Bilateral Hydronephrosis, Acquired Bilateral Hydronephrosis, Obstructive Bilateral Hydronephrosis, Non-Obstructive Bilateral Hydronephrosis For further insights on the Hydronephrosis market,
request a sample here

North America was the largest region in the hydronephrosis market in 2024. The regions covered in the hydronephrosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Hydronephrosis market, request a sample here.

Major companies operating in the hydronephrosis market are AbbVie Inc., Boston Scientific Corporation, Novartis AG, 3M Company, F. Hoffmann-La Roche Ltd, Medtronic PLC, Amgen Inc., Stryker Corporation, Thermo Fisher Scientific Inc., B. Braun Group, Terumo Interventional Systems, Sigma-Aldrich Co, Coloplast A/S, Cook Medical, KARL STORZ SE & Co. KG, Spire Healthcare Group plc, Promega Corporation, NantHealth Inc., UroGen Pharma Ltd., Natus Medical Incorporated, Renal Associates P.A., Urologix Inc., Savant Medical Group . For further insights on the Hydronephrosis market, request a sample here.

Major trends in the Hydronephrosis market include Advancements In Hydronephrosis Treatment Enhanced Patient Care. For further insights on the Hydronephrosis market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon